306 N-glycosylation inhibition hinders immunosuppressive tumor microenvironment cells improving CAR T cell efficacy
Main Authors: | Alice Bergamini, Barbara Camisa, Fabio Ciceri, Chiara Bonini, Monica Casucci, Beatrice Greco, Federica Pedica, Chiara Balestrieri, Laura Falcone, Miriam Redegalli, Elena Tiziano, Camilla Sirini, Giovanni Tonon, Rita El Khoury, Oronzina Botrugno |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2023-11-01
|
Series: | Journal for ImmunoTherapy of Cancer |
Similar Items
-
CD4 CAR-T cells targeting CD19 play a key role in exacerbating cytokine release syndrome, while maintaining long-term responses
by: Alice Bergamini, et al.
Published: (2023-01-01) -
1242 Mouse model of CAR-related ICANS development after treatment with human CD19 CAR-T cells
by: Alice Bergamini, et al.
Published: (2023-11-01) -
Regulatory T cells expressing CD19-targeted chimeric antigen receptor restore homeostasis in Systemic Lupus Erythematosus
by: M. Doglio, et al.
Published: (2024-03-01) -
Epithelial ovarian cancer is infiltrated by activated effector T cells co-expressing CD39, PD-1, TIM-3, CD137 and interacting with cancer cells and myeloid cells
by: Elena Tassi, et al.
Published: (2023-10-01) -
Genomic Instability and Replicative Stress in Multiple Myeloma: The Final Curtain?
by: Oronza A. Botrugno, et al.
Published: (2021-12-01)